Acute liver failure physical examination

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Acute liver failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Liver Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute liver failure physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute liver failure physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute liver failure physical examination

CDC on Acute liver failure physical examination

Acute liver failure physical examination in the news

Blogs on Acute liver failure physical examination

Directions to Hospitals Treating Acute liver failure

Risk calculators and risk factors for Acute liver failure physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Patients with acute liver failure may appear lethargic, anorexic and fatigue. In the initial stages of acute liver failure, the patient may have mild mental status changes such as altered sleep pattern but may become confused or develop coma in the later stages as the disease progresses. Physical examination of acute liver failure is remarkable for hepatomegaly, right upper quadrant abdominal tenderness, ascites and encephalopathy.

Physical Examination

Appearance of the Patient

  • Patient with acute liver failure may be appearing ill and lethargic.[1][2]
  • The patients with acute liver failure with mild mental status changes such as altered sleep pattern at initial stages may become confused or develop a comatose condition in the later stage.

Vital Signs

Skin

HEENT

Neck

Not significant

Lungs

Not significant

Heart

Not significant

Abdomen

Back

Not significant

Genitourinary

Not significant

Extremities

The extremities may have signs of easy bleeding due to coagulopathy.

Neuromuscular

Grades of Hepatic Encephalopathy

Based on their clinical manifestation, different grades of hepatic encephalopathy are defined as:[3]

  • Grade I
Grade I encephalopathy manifests with changes in behavior and minimal changes in the level of consciousness.
  • Grade II
Grade II encephalopathy manifests with inappropriate behavior, gross disorientation, drowsiness, and possibly asterixis.
  • Grade III
Grade III encephalopathy manifests with marked confusion, incoherent speech, and mostly sleeping but arousable to vocal stimuli.
  • Grade IV
Grade III encephalopathy manifests with comatose, unresponsive to pain, and decorticate or decerebrate posturing.

References

  1. Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K (2008). "Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis". Hepatol Res. 38 (10): 970–9. doi:10.1111/j.1872-034X.2008.00368.x. PMID 18462374.
  2. Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
  3. Conn, HO.; Leevy, CM.; Vlahcevic, ZR.; Rodgers, JB.; Maddrey, WC.; Seeff, L.; Levy, LL. (1977). "Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial". Gastroenterology. 72 (4 Pt 1): 573–83. PMID 14049.

Template:WH Template:WS